vs

Side-by-side financial comparison of HARROW, INC. (HROW) and Shimmick Corp (SHIM). Click either name above to swap in a different company.

Shimmick Corp is the larger business by last-quarter revenue ($141.9M vs $89.1M, roughly 1.6× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -3.1%, a 10.5% gap on every dollar of revenue. HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-28.7M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -10.1%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Shimmick Corp is a U.S.-based heavy civil construction firm specializing in building and upgrading critical public infrastructure, including water facilities, transportation systems, dams, and environmental remediation projects. It primarily serves federal, state, and local government clients across North America, delivering complex large-scale construction solutions for public sector segments.

HROW vs SHIM — Head-to-Head

Bigger by revenue
SHIM
SHIM
1.6× larger
SHIM
$141.9M
$89.1M
HROW
Higher net margin
HROW
HROW
10.5% more per $
HROW
7.4%
-3.1%
SHIM
More free cash flow
HROW
HROW
$36.8M more FCF
HROW
$8.1M
$-28.7M
SHIM
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
-10.1%
SHIM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
HROW
HROW
SHIM
SHIM
Revenue
$89.1M
$141.9M
Net Profit
$6.6M
$-4.4M
Gross Margin
79.3%
7.6%
Operating Margin
17.5%
-2.2%
Net Margin
7.4%
-3.1%
Revenue YoY
33.3%
Net Profit YoY
-2.2%
EPS (diluted)
$0.20
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
SHIM
SHIM
Q4 25
$89.1M
$141.9M
Q3 25
$71.6M
$128.4M
Q2 25
$63.7M
$122.1M
Q1 25
$47.8M
$103.6M
Q4 24
$66.8M
Q3 24
$49.3M
$166.0M
Q2 24
$48.9M
$90.6M
Q1 24
$34.6M
$120.0M
Net Profit
HROW
HROW
SHIM
SHIM
Q4 25
$6.6M
$-4.4M
Q3 25
$1.0M
$-8.5M
Q2 25
$5.0M
$-9.8M
Q1 25
$-17.8M
$-38.5M
Q4 24
$6.8M
Q3 24
$-4.2M
$-1.6M
Q2 24
$-6.5M
$-51.4M
Q1 24
$-13.6M
$-33.3M
Gross Margin
HROW
HROW
SHIM
SHIM
Q4 25
79.3%
7.6%
Q3 25
75.3%
6.3%
Q2 25
74.5%
3.8%
Q1 25
67.5%
-20.1%
Q4 24
78.8%
Q3 24
75.6%
7.3%
Q2 24
74.4%
-34.4%
Q1 24
69.5%
-13.2%
Operating Margin
HROW
HROW
SHIM
SHIM
Q4 25
17.5%
-2.2%
Q3 25
20.6%
-5.5%
Q2 25
17.9%
-7.3%
Q1 25
-23.5%
-39.3%
Q4 24
19.3%
Q3 24
2.7%
0.7%
Q2 24
3.1%
-53.0%
Q1 24
-20.0%
-26.5%
Net Margin
HROW
HROW
SHIM
SHIM
Q4 25
7.4%
-3.1%
Q3 25
1.4%
-6.6%
Q2 25
7.8%
-8.0%
Q1 25
-37.2%
-37.1%
Q4 24
10.1%
Q3 24
-8.6%
-0.9%
Q2 24
-13.2%
-56.7%
Q1 24
-39.2%
-27.8%
EPS (diluted)
HROW
HROW
SHIM
SHIM
Q4 25
$0.20
$-0.12
Q3 25
$0.03
$-0.25
Q2 25
$0.13
$-0.28
Q1 25
$-0.50
$-0.92
Q4 24
$0.19
Q3 24
$-0.12
$-0.05
Q2 24
$-0.18
$-1.83
Q1 24
$-0.38
$-1.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
SHIM
SHIM
Cash + ST InvestmentsLiquidity on hand
$72.9M
$17.6M
Total DebtLower is stronger
$250.0M
$57.5M
Stockholders' EquityBook value
$52.4M
$-52.7M
Total Assets
$399.5M
$218.5M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
SHIM
SHIM
Q4 25
$72.9M
$17.6M
Q3 25
$74.3M
$21.4M
Q2 25
$53.0M
$16.3M
Q1 25
$66.7M
$33.7M
Q4 24
$47.2M
Q3 24
$72.6M
$26.0M
Q2 24
$71.0M
$22.4M
Q1 24
$76.0M
$27.3M
Total Debt
HROW
HROW
SHIM
SHIM
Q4 25
$250.0M
$57.5M
Q3 25
$347.2M
$36.4M
Q2 25
$250.6M
$31.4M
Q1 25
$256.9M
$9.5M
Q4 24
$262.7M
Q3 24
$230.7M
$39.9M
Q2 24
$236.3M
Q1 24
$243.4M
$31.5M
Stockholders' Equity
HROW
HROW
SHIM
SHIM
Q4 25
$52.4M
$-52.7M
Q3 25
$47.0M
$-49.5M
Q2 25
$49.7M
$-42.6M
Q1 25
$56.5M
$-34.7M
Q4 24
$69.7M
Q3 24
$58.0M
$973.0K
Q2 24
$58.5M
$436.0K
Q1 24
$60.6M
$38.1M
Total Assets
HROW
HROW
SHIM
SHIM
Q4 25
$399.5M
$218.5M
Q3 25
$363.1M
$203.0M
Q2 25
$345.0M
$227.7M
Q1 25
$364.2M
$233.9M
Q4 24
$389.0M
Q3 24
$351.5M
$346.7M
Q2 24
$306.6M
$344.5M
Q1 24
$295.5M
$378.0M
Debt / Equity
HROW
HROW
SHIM
SHIM
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
41.01×
Q2 24
4.04×
Q1 24
4.02×
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
SHIM
SHIM
Operating Cash FlowLast quarter
$8.4M
$-23.7M
Free Cash FlowOCF − Capex
$8.1M
$-28.7M
FCF MarginFCF / Revenue
9.1%
-20.2%
Capex IntensityCapex / Revenue
0.4%
3.5%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$-27.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
SHIM
SHIM
Q4 25
$8.4M
$-23.7M
Q3 25
$16.6M
$-3.8M
Q2 25
$-803.0K
$-38.2M
Q1 25
$19.7M
$44.9M
Q4 24
$-17.8M
Q3 24
$3.0M
$12.7M
Q2 24
$-2.7M
$-43.9M
Q1 24
$-4.6M
$-35.0M
Free Cash Flow
HROW
HROW
SHIM
SHIM
Q4 25
$8.1M
$-28.7M
Q3 25
$16.4M
$-4.2M
Q2 25
$-969.0K
$-38.7M
Q1 25
$19.5M
$44.4M
Q4 24
$-18.3M
Q3 24
$2.3M
$10.3M
Q2 24
$-3.1M
$-46.8M
Q1 24
$-4.7M
$-39.6M
FCF Margin
HROW
HROW
SHIM
SHIM
Q4 25
9.1%
-20.2%
Q3 25
22.9%
-3.2%
Q2 25
-1.5%
-31.7%
Q1 25
40.8%
42.9%
Q4 24
-27.4%
Q3 24
4.8%
6.2%
Q2 24
-6.3%
-51.7%
Q1 24
-13.6%
-33.0%
Capex Intensity
HROW
HROW
SHIM
SHIM
Q4 25
0.4%
3.5%
Q3 25
0.3%
0.3%
Q2 25
0.3%
0.4%
Q1 25
0.4%
0.5%
Q4 24
0.8%
Q3 24
1.2%
1.4%
Q2 24
0.7%
3.3%
Q1 24
0.3%
3.8%
Cash Conversion
HROW
HROW
SHIM
SHIM
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

SHIM
SHIM

Shimmick Projects$106.8M75%
Non Core Projects$35.1M25%

Related Comparisons